These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32477121)

  • 1. Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.
    Li W; Peng X; Lang J; Xu C
    Front Pharmacol; 2020; 11():631. PubMed ID: 32477121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of MDM2 in Promoting Genome Stability versus Instability.
    Saadatzadeh MR; Elmi AN; Pandya PH; Bijangi-Vishehsaraei K; Ding J; Stamatkin CW; Cohen-Gadol AA; Pollok KE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine double minute 2: p53-independent roads lead to genome instability or death.
    Bouska A; Eischen CM
    Trends Biochem Sci; 2009 Jun; 34(6):279-86. PubMed ID: 19447627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2 affects genome stability independent of p53.
    Bouska A; Eischen CM
    Cancer Res; 2009 Mar; 69(5):1697-701. PubMed ID: 19244108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.
    Carr MI; Jones SN
    Transl Cancer Res; 2016 Dec; 5(6):707-724. PubMed ID: 28690977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis.
    Lehman JA; Mayo LD
    Int J Mol Sci; 2012 Dec; 13(12):16373-86. PubMed ID: 23208375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 oncogene as a novel target for human cancer therapy.
    Zhang ; Wang H
    Curr Pharm Des; 2000 Mar; 6(4):393-416. PubMed ID: 10788589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multifunctionality of MDM2 protein and its role in genomic instability of cancer cells].
    Małuszek M
    Postepy Biochem; 2015; 61(1):42-51. PubMed ID: 26281353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine.
    Qin JJ; Li X; Hunt C; Wang W; Wang H; Zhang R
    Genes Dis; 2018 Sep; 5(3):204-219. PubMed ID: 30320185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MDM2 Stability After DNA Damage.
    Li J; Kurokawa M
    J Cell Physiol; 2015 Oct; 230(10):2318-27. PubMed ID: 25808808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment.
    Gupta A; Shah K; Oza MJ; Behl T
    Biomed Pharmacother; 2019 Jan; 109():484-492. PubMed ID: 30551517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.
    Khosravi R; Maya R; Gottlieb T; Oren M; Shiloh Y; Shkedy D
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14973-7. PubMed ID: 10611322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells.
    Carrillo AM; Hicks M; Khabele D; Eischen CM
    Mol Cancer Res; 2015 Aug; 13(8):1197-205. PubMed ID: 25964101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mdm2 proto-oncogene.
    Haines DS
    Leuk Lymphoma; 1997 Jul; 26(3-4):227-38. PubMed ID: 9322885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
    Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53.
    Stoll R; Renner C; Hansen S; Palme S; Klein C; Belling A; Zeslawski W; Kamionka M; Rehm T; Mühlhahn P; Schumacher R; Hesse F; Kaluza B; Voelter W; Engh RA; Holak TA
    Biochemistry; 2001 Jan; 40(2):336-44. PubMed ID: 11148027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
    Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
    Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMX under stress: the MDMX-MDM2 complex as stress signals hub.
    de Polo A; Vivekanandan V; Little JB; Yuan ZM
    Transl Cancer Res; 2016 Dec; 5(6):725-732. PubMed ID: 30319942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.